Target Identification in Lupus Grant

The Alliance for Lupus Research (ALR) is pleased to announce that the applications for the ALR's Target Identification in Lupus (TIL) grants are now available online. Access the site directly at https://proposalcentral.altum.com.

Investigators seeking to submit grants applications will be eligible to receive a 2-year award for up to $500,000 with an opportunity to apply for continued funding.

Please view the Program Guidelines for a full description.
Target Identification in Lupus Program Frequently Asked Questions .

Associated deadline dates are as follows:

Letter of Intent:                  Due to ALR on May 20, 2009

Grant Applications:            Due to ALR on July 30, 2009

The ALR funds research that will accelerate the development of new treatments of lupus. As such, grant proposals should be innovative in direction and utilize state-of-the-art techniques. Fundamental studies in genetics, immunology, cell biology and molecular biology to identify and characterize molecular systems must be oriented towards the development of drugs that would prevent and/or ameliorate clinical signs and symptoms of lupus.

Individuals with doctoral degrees (MD, PhD or equivalent) are eligible to apply. Scientific independence, as evidenced by direction of a research program or a publication record or other experience that establishes scientific leadership, is necessary to apply. The ALR does not impose geographic restrictions on its applicants and investigators working anywhere in the world are eligible and encouraged to apply. The ALR is willing to appropriately support research in industry or collaborations between academia and industry.

If you have any questions or require any additional information regarding the application process, please contact Diomaris Gonzalez, Assistant Director of Research Administration at (212) 218-2840, (800) 867-1743 or at dgonzalez@lupusresearch.org.